Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LERICHE

Showing results (461-470 of 463) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 463 results.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KJacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitorElise Isabel, Kevin P Bateman, Nathalie Chauret, et al.
Tribology Letters|July 29, 2025
The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of TopographyA Pradhan, M H Müser, N Miller, et al.
Pageof 47

Showing results (461-470 of 463) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 463 results.
Bioorganic & Medicinal Chemistry Letters|January 30, 2008
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KJacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
The discovery of MK-0674, an orally bioavailable cathepsin K inhibitorElise Isabel, Kevin P Bateman, Nathalie Chauret, et al.
Tribology Letters|July 29, 2025
The Surface-Topography Challenge: A Multi-Laboratory Benchmark Study to Advance the Characterization of TopographyA Pradhan, M H Müser, N Miller, et al.
Pageof 47